Aitia uses AI and digital twins to discover breakthrough drugs.
What is Aitia?
Aitia is a biotechnology company that utilizes causal artificial intelligence, multi-omics data, and twin digital models to discover the next generation of breakthrough medications. Its mission is to become a leading artificial intelligence-driven biotech enterprise, accelerating the development of life-saving therapies and genuinely improving patients’ lives. By employing causal artificial intelligence, multi-omics patient data, and the resulting twin digital models, Aitia uncovers the hidden biological mechanisms behind various diseases.
How to use Aitia?
The website provides information regarding Aitia’s scientific activities, partnerships, news, publications, and career opportunities. You can explore their artificial intelligence-driven drug development pipeline, learn more about their team, and view details of their strategic partnerships. Contact information is also available on the site.
The core features of Aitia
Causal AI-driven drug discovery
The twin-digit model used for disease modeling
Multi-omics patient data analysis
The AI-driven pipeline of this pioneering project